Home / Conditions / Failure To Thrive

Failure To Thrive: when insurers say no, reviewers often say yes

In 13 published external-review decisions involving failure to thrive, independent physician reviewers overturned the insurer’s denial 76.9% of the time.

Published decisions
13
2001–2026
Overturned
76.9%
10 denials reversed
Typical time to a decision
7 days
Most land between 3 and 21 days
Handled as urgent
61.5%
Expedited when a delay would cause harm
What the reviewers wrote
Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Nature of Statutory Criteria/ Case Summary: The enrollee’s parent is requesting reimbursement for intensive tube weaning program services. The enrollee has diagnoses of hypertrophic cardiomyopathy and Noonan’s syndrome. He was an oral eater until approximately three months of age. He breast-fed for the first four weeks of his life and transitioned to bottle feeding. His family observed loud breathing, frequent vomiting, and poor weight gain during this time. He was hospitalized at one and a half months for 10 days due to recurrent vomiting and failure to thrive. He underwent a supraglottoplasty for his laryngomalacia and tracheomalacia. He was hospitalized one month later for recurrent vomiting, chronic upper respiratory infections, and failure to thrive. A nasogastric (NG) tube was placed due to decreased weight gain, feeding refusal, and failure to thrive.
Medical Necessity · 2019 · IMR MN19-31860
Nature of Statutory Criteria/Case Summary: The patient’s parent has requested authorization and coverage for in-home private during nursing home services. Kuo and colleagues noted that the parents of medically complex children with special health care needs spend an average of nearly nine hours per day managing the patient’s basic healthcare needs, such as personal hygiene and feeding, administering drugs and managing symptoms, pain and sleep related problems during the night. Current data shows that the number of medical appliances and the status of single caregivers correlated proportionally with a greater amount of time needed for the patient’s care. It is important for patients’ families to receive appropriate support with daily care tailored to the patient’s individual needs.
Medical Necessity · 2020 · IMR MN20-33820

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: The patient’s parent has requested authorization and coverage for continued in-home private duty nursing services for 86 hours per week. Home based nursing services are essential for the parents of young patients with life-limiting or life-threatening diseases who spend an average of nearly nine hours per day managing the patient’s basic healthcare needs such as personal hygiene and feeding, administering drugs and managing symptoms like seizures, pain, and sleep related problems during the night. Current data shows that the number of medical appliances and the status of single caregivers correlated proportionally with a greater amount of time needed for the patient’s care. It is important for these families to receive appropriate support with daily care, through the evaluation of individual needs of the patient and organization of care models.
Medical Necessity · 2021 · IMR MN21-35446
Nature of Statutory Criteria/Case Summary: The parent of an enrollee has requested Genotropin growth hormone (GH) therapy for treatment of the enrollee’s short stature. The physician reviewer found that this patient has failure to thrive and constitutional delay in association with a chronic inflammatory condition. Although his testing revealed a peak GH response of less than 10 ng/mL to provocative testing, such testing has poor specificity for the diagnosis of GH deficiency in a patient with delayed puberty who is also underweight. In addition, a low IGF-1 level in a patient who is underweight is not specific for GH deficiency. There is also a lack of biochemical evidence that this patient has other pituitary deficiencies to raise concern about a broader diagnosis of hypopituitarism.
Medical Necessity · 2015 · IMR MN15-20795

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.

How to use this in your appeal

These outcomes come from California’s external review program — an independent physician panel whose decision binds the insurer. Every state has an equivalent, and internal appeals succeed even more often. If your care for failure to thrive was denied, the published record says the denial is worth fighting.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Fighting a denial for failure to thrive? 76.9% won.

Explain my denial — freeStart my appeal · $39